44 search results for: chronic inflammation

EAACI 2024 | On-Treatment Clinical Remission in Upper and Lower Airways: ​ Going Beyond Symptom Control​
Congress
31
May
2024
Congress
EAACI 2024 | On-Treatment Clinical Remission in Upper and Lower Airways: ​ Going Beyond Symptom Control​

Join experts G. Walter Canonica, Vibeke Backer, and Joaquim Mullol for an educational symposium on elevating treatment goals from control to remission in the upper and lower airways.

UEG Upcoming Events Carousel Thumbnail
On Demand
Bridging the Gap in EoE: Innovative Strategies for Seamless Transition of Care

Join leading experts in EoE, Thomas Greuter, MD, Edoardo Vincenzo Savarino, MD, PhD, and Carla Giordano, MD, PhD, as they use a case-based approach to explore the impact of chronic type 2 inflammation in EoE and outline strategies for optimizing transition of care and monitoring disease progression. They review the latest clinical evidence on therapeutic management and share insights from their own practice to support shared decision-making in the long-term care of EoE.

ADVENT On Air | Loss of Smell in CRSwNP Patients
Rhinology
ADVENT On Air | Loss of Smell in CRSwNP Patients
Podcast

Profs. Wytske Fokkens and Joaquim Mullol discuss the clinical significance of the loss of smell in patients with CRSwNP.

View more
Connecting Type 2 <b>Inflammation</b> to CRSwNP
Rhinology
Connecting Type 2 Inflammation to CRSwNP
expert video

Prof. Claus Bachert describes how type 2 inflammation drives CRSwNP.

View more
ERS-ISIAN 2025 | Type 2 <b>Inflammation</b> and Disease Control in CRSwNP: Current Perspectives and Future Directions
Rhinology
ERS-ISIAN 2025 | Type 2 Inflammation and Disease Control in CRSwNP: Current Perspectives and Future Directions
expert video

The ERS-ISIAN 2025 symposium, featuring Prof. Vibeke Backer and Prof. Sietze Reitsma, titled "Type 2 Inflammation and Disease Control in CRSwNP: Current Perspectives and Future Directions," will delve into the complexities of the role of type 2 inflammation in CRSwNP.

View more
ERS-ISIAN 2025 | Type 2 <b>Inflammation</b>: Links with Severe/Uncontrolled CRSwNP
Rhinology
ERS-ISIAN 2025 | Type 2 Inflammation: Links with Severe/Uncontrolled CRSwNP
expert video

Prof. Vibeke Backer provides an insightful presentation on the association of type 2 inflammation and the pathogenesis and management of severe and uncontrolled CRSwNP.

View more
Potential Role of Type 2 Inflammation in the Pathogenesis of CSU
Dermatology
Potential Role of Type 2 Inflammation in the Pathogenesis of CSU
expert video

Join Professor Hide as he describes the potential role of Type 2 inflammation in the pathogenesis of CSU.

View more
ADVENT at ERS-ISIAN 2025
On Demand
ERS-ISIAN 2025 | Type 2 Inflammation and Disease Control in CRSwNP: Current Perspectives and Future Directions

In this educational presentation, Profs. Vibeke Backer and Sietze Reitsma cover key aspects of type 2 inflammation and its role in the pathogenesis and management of CRSwNP and practical strategies for optimizing disease control and improving patient outcomes.

Digestive Disease Week 2024 | Washington D.C.
Awareness Day
18
May
2024
Awareness Day
Digestive Disease Week 2024 | Washington D.C.

Join ADVENT at the Digestive Disease Week 2024 Congress and visit the Sanofi and Regeneron Medical Booth # 1707.

IFOS 2023 | Type 2 <b>Inflammation</b> and Clinically Relevant Improvements in CRSwNP
On Demand
IFOS 2023 | Type 2 Inflammation and Clinically Relevant Improvements in CRSwNP

Dr. Stella Lee and Profs. Peter Hellings and Wytske Fokkens discuss type 2 inflammation, partnering with patients to improve outcomes, and real-world data on biologic effectiveness in CRSwNP.

Spotlight on Type 2 <b>Inflammation</b> in the Upper and Lower Airways
Pulmonology
Spotlight on Type 2 Inflammation in the Upper and Lower Airways
expert video

In this video soundbite from the EAACI 2025 symposium, Dr. Zuzana Diamant explains pathophysiological mechanisms underlying asthma and CRSwNP, and how type 2 inflammatory cytokines drive airway remodelling in patients with severe asthma. Additionally, patients with co-existing asthma and CRSwNP have a higher type 2 inflammatory burden than patients with asthma alone.

View more
ADVENT at ERS-ISIAN 2025
Congress
20
June
2025
Congress
ADVENT at ERS-ISIAN 2025

Join experts Vibeke Backer, MD, DMSC, and Sietze Reitsma, MD, at an educational symposium involving a comprehensive exploration of the type 2 inflammation and its pivotal role in the pathogenesis and management of CRSwNP.